openPR Logo
Press release

Male Hypogonadism Market - Rise In Awareness about the Available Treatment Options And Increase in Incidence of Male Hypogonadism Are Major Factors That Drive the Growth of the Market

02-19-2019 09:16 AM CET | Health & Medicine

Press release from: Allied Market Research

Male Hypogonadism Market

Male Hypogonadism Market

By 2022, the male gonadal stimulator market is estimated to reach $ 323 million by 2022 and is expected to grow at a CAGR of 3.1% from 2016 to 2022. The pituitary disease sector accounts for nearly half of the total market share in 2015 and is expected to remain dominant over the analysis period.

Hypogonadism in the male is a clinical condition in which the testes fail to produce sufficient testosterone, resulting in decreased development of muscle mass, loss of body hair growth, development of breast tissue and a lack of vocalization. Growth in the male hypogonadism market is due to increased prevalence and frequency of patients with testosterone deficiency, increased rates of infertility, and increased patient awareness of options for treating STDs according to certain campaigns conducted by governments. In addition, the risk of germs is very high in the elderly population and in obese and diabetic populations.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/1874

Key players have adopted product approval as their key strategy to cater to the changing needs of the industry. There is high competition among key players to launch innovative, technologically advanced products to increase their market share and serve the patients in a better way.

Major players operating in this market include
• AbbVie Inc.
• Allergan plc
• AstraZeneca plc
• Bayer AG
• Eli Lilly and Company Ltd.
• Endo International plc
• Merck & Co. Inc.
• Ferring Holding S.A.
• Finox Biotech
• IBSA Institut Biochimque SA
• Laboratoires Genevrier
• Teva Pharmaceutical Industries Ltd.

The increase in the elderly population and the occurrence of chronic lifestyle disorders (obesity and diabetes) are expected to further stimulate market growth. However, the high side effects of all testosterone products are expected to hamper the growth of the testosterone replacement therapy (TRT) segment in this market. Technology advancement is expected to provide new opportunities during the forecast period.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/1874

North America accounted for the majority of market share (more than three quarters) in 2015 and is expected to dominate throughout the forecast period. This is due to an increase in the population suffering from primary and secondary causes of hypogonadism and an increase in patient awareness of the usefulness of treatment options. The high adoption rate of high technology products and the presence of highly sophisticated medical infrastructure are expected to create new growth opportunities for key players in this market. Europe is expected to register the highest CAGR of 7.2% during the analysis period with an increase in the adoption of western lifestyle, an increase in unhealthy eating habits, and an increase in the population with hypogonadism. Growth of urbanization.

Key Findings of the Male Hypogonadism Market
• By drug therapy, gonadotropin and gonadotropin-releasing hormones therapy segment is projected to grow at the highest CAGR of 8.9% during the forecast period.
• Pituitary disorders segment is expected to grow at the CAGR of 3.2%.
• Injectables accounted for nearly half of the market share in 2015.
• North America accounted for majority of the share (more than three-fourths) in 2015, and is expected to remain dominant throughout the forecast period.
• U.S. accounted for the majority share in the North American market in 2015, and the Mexican market is expected to grow at the highest CAGR of 6.7%.

Access Full Summery @ https://www.alliedmarketresearch.com/male-hypogonadism-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Male Hypogonadism Market - Rise In Awareness about the Available Treatment Options And Increase in Incidence of Male Hypogonadism Are Major Factors That Drive the Growth of the Market here

News-ID: 1598687 • Views:

More Releases from Allied Market Research

SOC as a Service Market Share Reach USD 9.9 Billion by 2031
SOC as a Service Market Share Reach USD 9.9 Billion by 2031
Allied Market Research published a new report, titled, " The SOC as a Service Market Share Reach USD 9.9 Billion by 2031." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps
A Look at the Microbial Incubators Market | Is Projected to Reach $508.5 Million By 2032
A Look at the Microbial Incubators Market | Is Projected to Reach $508.5 Million …
Microbial incubators, those unsung heroes of countless laboratories, are the controlled environments where the tiny powerhouses of life - microbes - flourish. From culturing bacteria for medical research to fostering yeast strains for beer production, these incubators are vital tools across various scientific disciplines. The global microbial incubators market size was valued at $315.2 million in 2022, and is projected to reach $508.5 million by 2032, growing at a CAGR
Market Growth of Automotive RADAR Industry : $4.08 Billion in 2020, Projected to Reach $10.06 Billion by 2028, CAGR of 12.6% (2021-2028)
Market Growth of Automotive RADAR Industry : $4.08 Billion in 2020, Projected to …
According to a recent report published by Allied Market Research, titled, "Automotive RADAR Market Size, Share, Competitive Landscape and Trend Analysis Report by Application, Frequency, Range and Vehicle Type Global Opportunity Analysis and Industry Forecast, 2021-2028". 𝐀𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐑𝐀𝐃𝐀𝐑 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐚𝐭𝐢𝐬𝐭𝐢𝐜𝐬 𝟐𝟎𝟐𝟏-𝟐𝟎𝟐𝟖 : The global automotive RADAR market was valued at $4.08 billion in 2020, and is projected to reach $10.06 billion by 2028, registering a CAGR of 12.6%. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬
Off-Road Vehicle Market : $12.37 Billion in 2020, Projected to Reach $22.62 Billion by 2030, CAGR of 7.3% (2021-2030)
Off-Road Vehicle Market : $12.37 Billion in 2020, Projected to Reach $22.62 Bill …
According to a recent report published by Allied Market Research, titled, "Off-Road Vehicle Market Size, Share, Competitive Landscape and Trend Analysis Report by Displacement, Vehicle Type, End Use Vertical : Global Opportunity Analysis and Industry Forecast, 2021-2030." 𝐎𝐟𝐟-𝐑𝐨𝐚𝐝 𝐕𝐞𝐡𝐢𝐜𝐥𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐚𝐭𝐢𝐬𝐭𝐢𝐜𝐬 𝟐𝟎𝟐𝟏-𝟐𝟎𝟑𝟎 : The global off-road vehicle market was valued at $12.37 billion in 2020, and is projected to reach $22.62 billion by 2030, registering a CAGR of 7.3% from 2021

All 5 Releases


More Releases for Hypogonadism

China Male Hypogonadism Market 2022 | Detailed Report
The research reports on "Male Hypogonadism Market" report gives detailed overview of factors that affect global business scope. Male Hypogonadism Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5062760 The
Global Transdermal Testosterone Market Size, Share & Trends Analysis Report, By …
The global transdermal testosterone market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Testosterone transdermal, also known as a patch, is used for the treatment of males whose bodies do not make enough natural testosterone; a condition called hypogonadism. Testosterone is a male hormone responsible for the growth and development of the male sex organs and maintenance of secondary sex characteristics. These transdermal contain testosterone,
Male Hypogonadism-Epidemiology Forecast to 2027
Publisher's "Male Hypogonadism-Epidemiology Forecast, 2027" report provides a comprehensive analysis of the Male Hypogonadism epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets Covered -United States -EU5 (Germany, France, Italy, Spain, and the United Kingdom) -Japan Study Period: 2016-2027 Male Hypogonadism Epidemiology The epidemiology section covers the historical, current as well as forecasted epidemiology for Male Hypogonadism in 7 major markets. The data is collected by understanding
Male Hypogonadism: North America to Remain Largest Market for Male Hypogonadism …
The report "Global Market Study on Male Hypogonadism: North America to Remain Largest Market for Male Hypogonadism during 2017 - 2026 ", has been prepared based on an in-depth market analysis with inputs from industry experts. Male hypogonadism is a condition in males wherein the testes depict a significantly reduced functioning level than normal. Reduction in rate of biosynthesis of the male sex hormones consequently results into male hypogonadism, which can
Male Hypogonadism Market Growth Contemplation By 2025
Global Male Hypogonadism Market: Snapshot Hypogonadism in males refers to a condition in the male body where the testes show a significantly reduced level of functioning than normal. The overall result of male hypogonadism is a reduction in the rate of biosynthesis of male sex hormones. This state is more commonly known as interrupted stage 1 puberty. Hypoandrogenism, or the low androgen or testosterone level in a male can vary in
Male Hypogonadism - Pipeline Review, H1 2017
ReportsWeb.com has announced the addition of the “Male Hypogonadism - Pipeline Review, H1 20172017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. Male hypogonadism is a condition in which the body doesn't produce enough testosterone. Symptoms include fatigue, hot flashes, infertility, decrease in muscle mass and loss of bone mass (osteoporosis). Risk factors for hypogonadism include HIV/AIDS, Klinefelter syndrome, Kallmann